Related Experiment Videos
32P-postlabelling analysis of DNA from human tissues
M N Routledge1, R C Garner, D Jenkins
1Jack Birch Unit for Environmental Carcinogenesis, Department of Biology, University of York, Heslington, UK.
Mutation Research
|July 1, 1992
Summary
Smoking is linked to higher levels of aromatic carcinogen DNA adducts in lung tissue and a weaker association in bladder tissue. These DNA adducts were also found in other human organs.
Area of Science:
- Environmental Health
- Toxicology
- Molecular Biology
Background:
- Aromatic carcinogens are environmental pollutants known to cause DNA damage.
- DNA adducts are biomarkers of exposure to carcinogens.
- Understanding adduct levels in various human tissues is crucial for risk assessment.
Purpose of the Study:
- To quantify aromatic carcinogen DNA adducts in human lung, bladder, liver, pancreas, cervix, and breast tissues.
- To investigate the association between smoking status and DNA adduct levels in these tissues.
Main Methods:
- DNA was extracted from autopsy tissue samples.
- The nuclease P1 enhancement modification of the 32P-postlabelling assay was used to detect aromatic carcinogen DNA adducts.
- Data from 56 sample sets (32 male, 24 female) were statistically analyzed.
Main Results:
- A strong trend of increased adduct levels was observed in the lung DNA of smokers compared to non-smokers.
- A weak association between smoking and increased bladder DNA adduct levels was found.
- Aromatic adducts were detected in other analyzed human tissues.
Conclusions:
- Smoking is a significant source of aromatic carcinogen DNA adducts in human lung tissue.
- Further research is warranted to explore the presence and implications of these adducts in other tissues.
- The 32P-postlabelling assay is a valuable tool for assessing exposure to aromatic carcinogens.